Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Future Of Lilly’s Arxxant In Doubt

This article was originally published in The Pink Sheet Daily

Executive Summary

Lilly says it is considering options for the investigational diabetic retinopathy treatment after FDA rejected the company's appeal of a recent "approvable" decision.

You may also be interested in...



Lilly Acquires Diabetes Candidates In Deal With Transition Therapeutics

After ending its efforts to develop inhaled insulin, Lilly rebuilds in-house pipeline of diabetes candidates.

Lilly Acquires Diabetes Candidates In Deal With Transition Therapeutics

After ending its efforts to develop inhaled insulin, Lilly rebuilds in-house pipeline of diabetes candidates.

Lilly To Appeal FDA Action On Arxxant Calling For Additional Clinical Trial

Company says Arxxant clinical data package presents a compelling case for the treatment of diabetic retinopathy.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS065759

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel